Recent reports of high dehydroascorbic acid levels in Asian subjects suffering from diabetes mellitus have led us to examine plasma dehydroascorbic acid levels in diabetic and non-diabetic Europeans. We can find no evidence that diabetic patients have higher plasma dehydroascorbic acid levels than nondiabetics, and consider some possible reasons for the discrepancy between this finding and those of earlier reports.
Introduction
In recent years there have been several reports of high dehydroascorbic acid (DHAA) concentrations both in the erythrocytes and the plasma of patients with diabetes mellitus (DM).I-4 Further, having shown high DHAA levels in some subjects who had a predisposition to the condition, it has been suggested that it would be possible to use blood DHAA measurements for the early detection of diabetes. I. 3 Apart from the aetiological implications, this would allow identification of 'high-risk' subjects, enabling them to be closely monitored.
We have, therefore, examined plasma DHAA levels in non-diabetic and diabetic subjects in the United Kingdom, to see if we could confirm these findings.
Subjects
Heparinised blood samples were taken from the first eight patients presenting at each of two out-patient diabetic clinics. The seventeenth patient was a member of the laboratory staff.
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They included both type I and II diabetics. Twelve non-diabetic control volunteers were also examined. All were members of the laboratory staff, and were not SUffering from any apparent illness. Relevant details are shown in Table 1 .
Materials and methods
Plasma ascorbic acid (AA) was measured using the method of Day, Williams and Marsh." This involves reduction of Fe3+ to Fe 2 + , the latter then reacting with 2,4,6-tripyridyl-s-triazine (TPTZ). Nine samples from diabetic patients and ten from control subjects were also analysed by the dichlorophenol indophenol (DCIP) technique" since this has been used by others:' to measure AA. Total vitamin C was measured using the technique of Roe and Kuether" using 2,4-dinitrophenylhydrazine (DNPH). DHAA was calculated as (total vitamin C-AA). This introduces a slight error, since a small amount of diketogulonic acid (DKGA), a breakdown product of AA, is also measured by the DNPH technique. However, the concentration of DKGA is very small, and we, like others' have 
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disregarded its contribution to total vitamin C when calculating DHAA.
Blood samples were collected into tubes containing lithium heparin and the plasma was separated by centrifugation within 30 min of venepuncture. Plasma was then added to two volumes of 600 mmol/L trichloroacetic acid, except for analysis by the DCIP technique when two volumes' of plasma were added to three volumes 30 giL metaphosphoric acid. The samples were then centrifuged, the supernatants decanted, and either analysed immediately for AA or stored at -20°C for up to 1 week for analysis of total vitamin C. Thus, analysis of plasma AA levels was completed within 60 min of venepuncture.
Blood glucose levels were measured using a Yellow Springs Model 23AM glucose analyser (Clandon Scientific Ltd), using samples anticoagulated with fluoride oxalate.
Results and discussion Table 2 shows plasma AA, DHAA and total vitamin C in controls and diabetic subjects and shows the percentage of total vitamin C present as DHAA in the two groups compared with the results of others.v" The proportion of total vitamin C present as DHAA is low and the concentration is similar in both non-diabetic and diabetic subjects. These findings are in contrast with those reported from the studies in India 2 -4 where differences were found between the plasma DHAA levels in non-diabetic and diabetic patients and where, in the diabetic group, the DHAA represented a large proportion of the total vitamin C. The discrepancy between the results for diabetic patients in the studies is accounted for by the lower concentration of DHAA and the much higher concentration of total vitamin C reported here.
We have considered a number of possibilities for these discrepancies. It is unlikely that the differences in type or severity of diabetes mellitus is the explanation since a high proportion of DHAA has been found in the plasma of diabetics whatever their treatment, duration of illness or blood glucose levels." In addition, although the number of subjects studied in this report is small, we have measured total vitamin C in 118 diabetics and have found similar values to those reported here (46±26 umol/L mean ± SD). The diabetics examined in this study therefore, seem typical of the diabetic population of this area.
Differences in technique are unlikely to explain the differences seen. Total vitamin C was measured by the same procedure here and in the other studies. Banerjee) used reduction of DCIP to measure AA, rather than the TPTZ technique we used. However, these two techniques give comparable results in both normal and diabetic subjects, the regression equation which we found being AA(DCIP)=1·002xAA(TPTz)+0·06; r=0·986. However, it may be possible to account for some of the differences between this study and earlier reports in terms of the instability of AA, which can be rapidly oxidised to DHAA and other oxidation projects during preparation of the sample." We analysed AA within 60 min of venepuncture, but longer periods have been allowed by others.v :' Greater conversion of AA to DHAA during their extended preparation time could possibly account for the higher concentration of DHAA found. In addition, many of the Indian subjects studied had a low total plasma vitamin C concentration, so almost any conversion of AA to DHAA would result in the accumulated DHAA becoming a large proportion of the total vitamin C. However, the difference between the proportion of DHAA in controls and diabetics found by others is not accounted for by this explanation as there is no evidence that AA is oxidised more rapidly in blood taken from diabetics than it is in blood from non-diabetics (Table 3 ). Finally, it is possible that racial differences in the metabolism of vitamin C might account for the discrepancies seen." Although all our assessments have been made on plasma samples, some reports/: 3 have demonstrated a more striking elevation of DHAA concentrations in the red cells of diabetic patients than in the plasma. We did not measure erythrocyte AA levels because of technical difficulties caused by oxidation of AA to DHAA by haemoglobin during protein precipitation, a problem reported to be overcome by treating samples with carbon monoxide before protein precipitation.v 3 It is possible therefore that cellular DHAA levels are higher in diabetics than non-diabetics. However, this needs to be confirmed in view of the findings of this study which do not provide any support for a difference between diabetic and non-diabetic subjects in the proportions of plasma vitamin C present as AA and DHAA.
